Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Faller, Bryan

Decatur Memorial Hospital
United States

Heartland Cancer Research NCORP 3UG1CA189830-11S1 Vanessa A. White, M.P.H.
Faller, Bryan

Decatur Memorial Hospital
United States

Heartland Cancer Research NCORP 3UG1CA189830-11S1 Vanessa A. White, M.P.H.
Farrar, Christian T

Massachusetts General Hospital
United States

Novel metabolomic contrast probes for human lung cancer characterization 4R01CA273010-04 Guillermo Marquez, Ph.D.
Feng, Ziding

Fred Hutchinson Cancer Center
United States

Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) 5U24CA230144-09 Guillermo Marquez, Ph.D.
Fiol, Guilherme Del

University Of Utah
United States

GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management 5U24CA274582-03 Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L.

University Of Illinois At Chicago
United States

Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk 5R01CA250390-05 Young Kim, Ph.D.
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flory, James H

Sloan-Kettering Inst Can Research
United States

Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life 5R21CA277464-02 Gabriela Riscuta, M.D., CNS
Flowers, Lisa C.

Emory University
United States

Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH) 5UG1CA284884-03 Maria Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.

Emory University
United States

Screening Strategies Among High-Risk Populations for Anal Cancer 5R01CA285198-03 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 5R01CA285925-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Flynn, Kathryn E

Medical College Of Wisconsin
United States

Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM) 5R01CA285925-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Forsberg, Flemming

Thomas Jefferson University
United States

Prostate Cancer Diagnosis by Multiparametric Ultrasound 5R01CA252311-05
Frazier, Anne Lindsay

Dana-Farber Cancer Inst
United States

Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 5UH3CA240688-05 Nicholas Hodges, Ph.D.
Freedland, Stephen Jay

Cedars-Sinai Medical Center
United States

Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic Outcomes 3R01CA280081-03S1 Young Kim, Ph.D.